Drugs / Ringer's
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04235062 | Apr 2020 → Apr 2021 | heart failure | Momentum Research, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ringer's | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04235062 ↗ |
| Route | Intravenous | “Subject receive intravenous infusion of Ringer's (8.6 g/L sodium chloride, 0.33 g/L calcium chloride, 0.3 g/L potassium chloride) solution” NCT04235062 ↗ |